The biotech industry stands at a crossroads. Advances in AI and technology have accelerated scientific innovation, transforming how we develop vaccines and therapeutics. But the operational infrastructure supporting this progress has not evolved at the same pace, creating a chasm between what science can achieve and what patients can access. As scientists and engineers, we are driven to provide patients with the therapeutic outcomes needed to restore normalcy to their daily lives.

We built Dash with purpose, to bridge this divide. Unlike traditional bioanalysis providers, our company was built from day one around a tech-first philosophy by leveraging our team’s decades of industry expertise with AI, robotics and software. From our Boston headquarters, we’re proving that bioanalysis doesn’t have to be a bottleneck. When  patients can’t wait, speed and quality become non-negotiable. That’s why you will receive your sample analysis results in days, not weeks or months, fundamentally accelerating your development timelines.

For us, transparency is paramount. By publishing pricing directly on our website, you don’t need to do guesswork. Guaranteed timelines and outcomes remove uncertainty. You'll know exactly what to expect, when to expect it and what it costs. No surprises. That’s how it should be - we know from our own first hand experience. 

Imagine a world where collaboration with sponsors is intuitive, data flows seamlessly, and bringing a drug to market is faster than ever before. From early discovery through late-stage trials, we are on a mission to help you quickly move insights into action.